Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Pharmacotherapy|July 1, 1997
Symptomatic cardiotoxicity associated with 5-fluorouracilC C Meyer, K A Calis, L B Burke, et al.Pharmacotherapy|July 25, 2000
Quality of pharmacotherapy consultations provided by drug information centers in the United StatesK A Calis, D W Anderson, D A Auth, et al.Clinical Pharmacy|February 1, 1991
Recombinant interleukin-2: a biological response modifierP E Kintzel, K A CalisClinical Pharmacy|August 1, 1990
Attention-deficit hyperactivity disorderK A Calis, D R Grothe, J EliaPharmacotherapy|March 24, 2000
Orlistat, a new lipase inhibitor for the management of obesityA M Heck, J A Yanovski, K A CalisClinical Pharmacy|January 1, 1992
Transdermally administered fentanyl for pain managementK A Calis, D R Kohler, D M CorsoScience (New York, N.Y.)|June 29, 1973
Testosterone concentration in the male chick brain: an autoradiographic surveyC C MeyerClinical Cardiology|November 30, 2000
Bosentan and the endothelin system in congestive heart failureS H Ellahham, V Charlon, Z Abassi, et al.The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasiaD P Merke, D Cho, K A Calis, et al.Pageof 3